Parametric Portfolio Associates LLC trimmed its position in shares of RadNet, Inc. (NASDAQ:RDNT) by 37.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 99,182 shares of the medical research company’s stock after selling 60,282 shares during the period. Parametric Portfolio Associates LLC owned about 0.21% of RadNet worth $769,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of RadNet by 4.2% during the second quarter. Vanguard Group Inc. now owns 1,284,852 shares of the medical research company’s stock worth $9,957,000 after acquiring an additional 51,229 shares in the last quarter. Northern Trust Corp raised its holdings in shares of RadNet by 5.2% during the second quarter. Northern Trust Corp now owns 436,407 shares of the medical research company’s stock worth $3,382,000 after acquiring an additional 21,746 shares in the last quarter. Citigroup Inc. raised its holdings in shares of RadNet by 3.5% during the second quarter. Citigroup Inc. now owns 66,202 shares of the medical research company’s stock worth $513,000 after acquiring an additional 2,245 shares in the last quarter. Ativo Capital Management LLC purchased a new stake in shares of RadNet during the second quarter worth $961,000. Finally, TIAA CREF Investment Management LLC raised its holdings in shares of RadNet by 19.7% during the second quarter. TIAA CREF Investment Management LLC now owns 124,612 shares of the medical research company’s stock worth $966,000 after acquiring an additional 20,520 shares in the last quarter. Institutional investors and hedge funds own 50.32% of the company’s stock.

In other news, Director Lawrence L. Levitt sold 6,189 shares of RadNet stock in a transaction dated Tuesday, September 19th. The stock was sold at an average price of $11.04, for a total value of $68,326.56. Following the transaction, the director now directly owns 198,937 shares in the company, valued at $2,196,264.48. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director David L. Swartz sold 25,000 shares of RadNet stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $10.98, for a total value of $274,500.00. Following the completion of the transaction, the director now owns 274,108 shares in the company, valued at $3,009,705.84. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,248,296 shares of company stock worth $13,607,995. Corporate insiders own 9.36% of the company’s stock.

RadNet, Inc. (NASDAQ RDNT) opened at $9.85 on Tuesday. RadNet, Inc. has a 1-year low of $5.25 and a 1-year high of $11.90. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 7.88. The firm has a market capitalization of $465.52, a PE ratio of 32.67, a price-to-earnings-growth ratio of 3.29 and a beta of 0.87.

RadNet (NASDAQ:RDNT) last posted its earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.12. RadNet had a return on equity of 23.73% and a net margin of 1.21%. The company had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. During the same period last year, the company earned $0.11 earnings per share. The business’s revenue was up 1.3% compared to the same quarter last year. equities research analysts anticipate that RadNet, Inc. will post 0.35 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This news story was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.thecerbatgem.com/2017/11/21/parametric-portfolio-associates-llc-sells-60282-shares-of-radnet-inc-rdnt.html.

Several analysts recently issued reports on RDNT shares. Zacks Investment Research upgraded RadNet from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th. Jefferies Group LLC upgraded RadNet from a “hold” rating to a “buy” rating and raised their target price for the company from $7.00 to $12.00 in a report on Tuesday, August 22nd. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. Finally, TheStreet lowered RadNet from a “b-” rating to a “c” rating in a report on Friday, October 27th.

RadNet Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Want to see what other hedge funds are holding RDNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RadNet, Inc. (NASDAQ:RDNT).

Institutional Ownership by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Stock Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related stocks with our FREE daily email newsletter.